HIGH LEVEL OF IL -1 RECEPTOR ANTAGONIST AS A LETHALITY FACTOR IN PATIENTS WITH SURGICAL SEPSIS
https://doi.org/10.15789/1563-0625-2009-2-3-287-288
Abstract
Absract. The data are presented that concern the levels of IL-1 receptor antagonist (IL-1 Ra) in blood serum of twenty-five patients with severe surgical sepsis. Sixteen patients recovered from the condition, whereas lethal outcome was registered in nine cases. The study was performed by means of immunoassay, using «IFA-Best IL-1 Ra» kits supplied by the Vector-Best firm. Only three patients showed IL-1 Ra contents within normal limits, whereas others exhibited marked increase in IL-1 Ra levels, up to a mean of 2443.656±382.85 pg/ml (normal range, 50 to 1000 pg/ml).
About the Authors
V. V. GrebenyukRussian Federation
G. A. Makarova
Russian Federation
N. V. Yusan
Russian Federation
References
1. Останин А.А., Леплина О.Ю., Тихонова М.А., Зайнутдинов Ю.Г., Стрельцова Е.И., Овечкин А.В., Черных Е.Р. Хирургический сепсис. Часть I. Иммунологические маркеры системной воспалительной реакции // Вестник хирургии. – 2002. – № 3. – С. 10-107.
2. Останин А.А., Леплина О.Ю., Шевела Е.Р. Оценка цитокинового профиля у больных с тяжелым сепсисом методом проточной флюориметрии (Bio – Plex – анализа) // Цитокины и воспаление. – 2004. – Т. 3, № 1. – С. 20-27.
3. Белобородов В.Б., Гельфанд Б.Р., Городецкий В.М., Деревянко И.И., Ерюхин И.А., Руднов В.А., Светухин А.М., Шляпников С.А., Звягин А.А., Жуков А.О. Стандарты классификации, диагностики и лечения хирургического сепсиса // Хирургия. – 2002. – № 8. – С. 67-68.
4. Bone R.C. Sir Isaac Newton. Sepsis, Sirs, and Cars // Crit. Care Med. – 1996. – N 24. – P. 1125 - 1129.
5. Bone R.C., Godzin C.J., Balk R.A. Sepsis: a new hypothesis for pathogenesis of the disease process // Chest. – 1997. – Vol. 112. – P. 235-243.
Review
For citations:
Grebenyuk V.V., Makarova G.A., Yusan N.V. HIGH LEVEL OF IL -1 RECEPTOR ANTAGONIST AS A LETHALITY FACTOR IN PATIENTS WITH SURGICAL SEPSIS. Medical Immunology (Russia). 2009;11(2-3):287-288. (In Russ.) https://doi.org/10.15789/1563-0625-2009-2-3-287-288